Guangdong Fapon Biotech Co. Ltd.,

Guangdong Fapon Biotech Co. Ltd. specializes in specimen stabilization reagents for in vitro diagnostics (IVD). These reagents are formulated to maintain the integrity of biological samples during transport and storage, ensuring reliable results for laboratory testing. The company’s focus is on preserving sample stability, which is critical for accurate diagnostic processes.

The company is based in the United States, which means its devices must comply with U.S. medical device regulations. Since its products fall under FDA’s Class I classification, they are subject to general controls but do not require premarket approval. This classification reflects their lower risk profile, though compliance with FDA’s Unique Device Identifier (UDI) requirements remains mandatory for traceability and transparency.

Yes, the company’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is essential for tracking medical devices throughout their lifecycle, ensuring patient safety, and facilitating regulatory oversight. Listing in the UDI system helps healthcare providers, regulators, and manufacturers verify device authenticity and compliance with U.S. standards.

The company’s devices are classified as Class I by the FDA. This classification indicates they pose minimal risk to patients and users, requiring only general controls (such as proper labeling and manufacturing practices) rather than stringent premarket reviews. Class I devices are typically simple in design and include items like specimen stabilization reagents, where the primary function is non-invasive and low-risk.